Attacking form of epilepsy, next-generation gene therapy company raises $135 million
July 22, 2020 at 10:50 AM EDT
The company, started five years ago by Kartik Ramamoorthi and Stephanie Tagliatela, has raised $290 million and will start a clinical trial next year against Dravet Syndrome.
